Edwards Lifesciences (EW) Research & Development (2009 - 2026)

Edwards Lifesciences' Research & Development history runs 18 years deep, the most recent figure standing at $263.3 million for Q1 2026.

• In Q1 2026, Research & Development rose 3.42% year-over-year to $263.3 million; the TTM figure through Mar 2026 stood at $1.1 billion (up 3.52% YoY), while the FY2025 annual figure was $1.1 billion, up 2.49% from the prior year.
• Research & Development was $263.3 million for Q1 2026 at Edwards Lifesciences, down from $267.7 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $280.7 million in Q3 2025 to a low of $130.6 million in Q4 2022.
• Historically, Research & Development has averaged $248.8 million across 5 years, with a median of $254.6 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Research & Development slumped 43.9% in 2022, then surged 85.38% in 2023.
• A 5-year view of Research & Development shows it stood at $130.6 million in 2022, then jumped by 85.38% to $242.1 million in 2023, then climbed by 11.98% to $271.1 million in 2024, then declined by 1.25% to $267.7 million in 2025, then dropped by 1.64% to $263.3 million in 2026.
• The last three Research & Development figures came in at $263.3 million (Q1 2026), $267.7 million (Q4 2025), and $280.7 million (Q3 2025), per Business Quant data.